Are hyaluronic acid injections available on the NHS? 

Hyaluronic acid injections, often referred to as viscosupplementation, are not routinely available on the NHS for the management of osteoarthritis. This treatment involves injecting a synthetic version of the synovial fluid, the lubricant naturally found in your joints, directly into the joint space to improve cushioning and reduce friction. While many individuals find these injections provide temporary relief from pain and stiffness, clinical guidelines in the United Kingdom suggest that the evidence for their effectiveness is inconsistent when compared to more established treatments. Consequently, the National Institute for Health and Care Excellence (NICE) recommends that healthcare professionals do not routinely offer them for osteoarthritis. Understanding why these injections are excluded from standard NHS care, and knowing which alternatives are provided, helps you make informed decisions about your joint health and explore all available pathways for maintaining your mobility. 

What We’ll Discuss in This Article 

• The clinical reasoning behind the NHS decision to not fund hyaluronic acid 

• Current NICE recommendations on viscosupplementation 

• How hyaluronic acid differs from the steroid injections offered by the NHS 

• Exceptions where the treatment might be considered on an individual basis 

• Accessing hyaluronic acid injections through private healthcare 

• Identifying common triggers that suggest alternative NHS treatments 

• The importance of focusing on core treatments like exercise and weight care 

Why the NHS does not routinely offer these injections 

The decision not to provide hyaluronic acid injections on the NHS is based on extensive reviews of clinical and cost-effectiveness. 

• Limited Clinical Benefit: While some studies show statistically significant pain reduction, many reviews conclude that the improvement is too small to be considered clinically important for the average patient. 

• The Placebo Effect: Clinical trials have frequently suggested that a significant portion of the relief reported by patients may be due to the ‘placebo effect’ rather than the substance itself. 

• NICE Guidance: The guidelines of UK clinical standards, the NICE guidelines, explicitly state that intra-articular hyaluronan injections should not be offered to manage osteoarthritis. 

• Cost vs. Value: The NHS prioritises funding for treatments that provide a clear and substantial benefit for the greatest number of people, such as physiotherapy and targeted weight management programs. 

Differentiating hyaluronic acid from steroid injections 

While hyaluronic acid is rarely funded, the NHS does routinely offer corticosteroid (steroid) injections for significant osteoarthritis flares. 

• Hyaluronic Acid: Acts as a lubricant and ‘shock absorber’; it is not a drug but a synthetic version of joint fluid. 

• Steroid Injections: These are powerful anti-inflammatory drugs that quickly reduce joint heat and swelling during a flare-up. 

• Availability: Steroid injections are widely available through GP surgeries and hospital clinics, whereas hyaluronic acid is almost exclusively accessed in the private sector. 

Your general practitioner will typically suggest a steroid injection if your symptoms are not responding to topical treatments and if the pain is preventing you from performing the strengthening exercises that provide real, long-term joint stability. 

Accessing the treatment privately 

Because hyaluronic acid is not routinely commissioned by the NHS, many people choose to seek this treatment through private clinics. 

• Self-Pay: Patients usually pay for the consultation and the injection themselves; costs can range from several hundred to over a thousand pounds depending on the brand used. 

• Private Insurance: Some private health insurance policies may cover these injections, but it is essential to check your specific policy details, as many follow the same restrictive guidelines as the NHS. 

• Specialist Assessment: In a private setting, a specialist—such as an orthopaedic surgeon or a sports medicine doctor—will assess if you are a suitable candidate for viscosupplementation. 

If you choose the private route, it is still recommended to keep your NHS GP informed so they can update your medical records and ensure any other treatments you receive are safe and coordinated. 

Investigating the causes of individual exceptions 

While not routinely funded, there are very rare ‘exceptional circumstances’ where a clinician might apply for individual funding through the NHS. This is typically only considered if a patient cannot take any other forms of pain relief and surgery is not an option. Each Integrated Care Board (ICB) in England has its own specific policy, but the ‘bar’ for such exceptions is extremely high. By investigating these options with your doctor, you can ensure that you have explored every possible pathway, though for the vast majority, the NHS will recommend focusing on core treatments like therapeutic exercise and weight care. 

Identifying triggers for alternative NHS support 

If you were hoping for hyaluronic acid injections to manage your joint pain, it may be because your current symptoms are making daily life difficult. These are triggers to discuss more established NHS support with your GP. 

• Losing Mobility: If you find you are walking less or avoiding social events due to pain. 

• Sleep Disturbance: The joint ache is waking you up at night. 

• Muscle Weakness: You feel the joint is becoming unstable or ‘giving way’. 

Rather than viscosupplementation, these triggers often lead to a referral for physiotherapy, a review of your topical pain relief, or, in advanced cases, a discussion about joint replacement surgery. 

Differentiation: Clinical evidence vs Personal experience 

It is essential to differentiate between the large-scale clinical evidence used by the NHS and individual personal experiences. Some people find that hyaluronic acid injections significantly improve their quality of life, which is why they remain popular in private practice. However, the NHS must rely on ‘strong conclusive evidence’ that a treatment works better than a placebo for the whole population before it can be funded by the taxpayer. By understanding this difference, you can balance the hope for relief with the reality of current medical guidelines, focusing your efforts on the core treatments that are proven to support long-term joint health. 

Conclusion 

Hyaluronic acid injections are not routinely available on the NHS for osteoarthritis due to a perceived lack of clinical cost-effectiveness and inconsistent evidence of their benefit over a placebo. While they are widely accessible through private healthcare for those willing to pay, the NHS prioritises core management strategies such as therapeutic exercise, weight care, and, when necessary, steroid injections. By working closely with your general practitioner and identifying the specific triggers for your discomfort, you can access the full range of supported NHS treatments designed to maintain your mobility and quality of life. Staying proactive about physical strengthening remains the most effective long-term way to protect your joints, regardless of the specific medical interventions you choose. 

If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot 

This article was written by Dr. Stefan Petrov, a UK-trained physician with an MBBS and postgraduate certifications including Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and the UK Medical Licensing Assessment (PLAB 1 & 2). He has hands-on experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov has worked in both hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient-focused health content and teaching clinical skills to junior doctors.